Ensayos clínicos

8.676 ensayos encontrados

ReclutandoClinicalTrials.gov

Proof-of-concept Case-control Study for Colorectal Cancer Assessment Using Delta-HLD Technology (CASCADE)

OBSERVATIONALInicio: 30 de jun de 2021ID: NCT07148297

Por invitaciónFase 2ClinicalTrials.gov

Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Achondroplasia: PROPEL OLE

INTERVENTIONALInicio: 6 de dic de 2021ID: NCT05145010

ReclutandoClinicalTrials.gov

Maternal Characteristics Associated With Child Growth and Adiposity. Search for Nutrigenomic Biomarkers in Peripheral Blood

OBSERVATIONALInicio: 2 de may de 2019ID: NCT05798676

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease

INTERVENTIONALInicio: 22 de dic de 2021ID: NCT05269394

CompletadoClinicalTrials.gov

Individualized Antiretroviral Therapy: Impact of Pharmacogenetic and Therapeutic Drug Monitoring in the Safety and Efficacy of First Line Antiretroviral Therapy in Patients With HIV Infection

INTERVENTIONALInicio: 5 de oct de 2017ID: NCT03385473

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults With Macular Neovascularization Secondary to Age-Related Macular Degeneration

INTERVENTIONALInicio: 22 de jul de 2025ID: NCT07064759

DesconocidoClinicalTrials.gov

Implementation of a Comprehensive Multi-level Molecular Strategy for the Identification of Genetic Alterations in Pediatric Solid Tumors Aimed at Achieving a Personalized Approach to the Patient

OBSERVATIONALInicio: 1 de feb de 2021ID: NCT04773808

TerminadoFase 1 tempranaClinicalTrials.gov

Phase 1 Suicide Plus Immune Gene Therapy for Advanced Melanoma

INTERVENTIONALInicio: 20 de feb de 2020ID: NCT03338777

CompletadoFase 2ClinicalTrials.gov

A Double-Blinded Randomized Placebo Controlled Study of Daily Pentoxifylline as a Rescue Treatment in DMD

INTERVENTIONALInicio: 1 de sept de 2005ID: NCT00243789

CompletadoClinicalTrials.gov

Rolandic Epilepsy Genomewide Association International Study

OBSERVATIONALInicio: 1 de jun de 2018ID: NCT03547050

ReclutandoClinicalTrials.gov

Clinical Validation Cross-sectional Study for Colorectal Cancer Assessment Using Delta-HLD Technology (CLIMBED)

OBSERVATIONALInicio: 4 de abr de 2024ID: NCT07168876

DesconocidoClinicalTrials.gov

Non-selection Trial Comparing Metabolomics to PGT-A Embryo Selection Using Vitrolife G-TL Media

OBSERVATIONALInicio: 12 de jul de 2021ID: NCT04976920

Activo, no reclutaFase 3ClinicalTrials.gov

HELIOS-B: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

INTERVENTIONALInicio: 26 de nov de 2019ID: NCT04153149

CompletadoClinicalTrials.gov

NordiNet® International Outcome Study-Observational Prospective Study on Patients Treated With Norditropin®

OBSERVATIONALInicio: 1 de abr de 2006ID: NCT00960128

CompletadoFase 3ClinicalTrials.gov

A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer

INTERVENTIONALInicio: 22 de feb de 2021ID: NCT04697628

CompletadoFase 3ClinicalTrials.gov

A Phase 2/3 Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

INTERVENTIONALInicio: 21 de ago de 2013ID: NCT01896102

Activo, no reclutaFase 3ClinicalTrials.gov

A Randomized, Open-Label, Phase 3 Study to Evaluate Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer With No Epidermal Growth Factor Receptor or Anaplastic Lymphoma Kinase Genomic Tumor Aberrations

INTERVENTIONALInicio: 12 de oct de 2022ID: NCT05502237

Activo, no reclutaFase 3ClinicalTrials.gov

A Randomized, Phase 3, Open-label Study to Evaluate Sigvotatug Vedotin Compared With Docetaxel in Adult Participants With Previously Treated Non-small Cell Lung Cancer (Be6A Lung-01)

INTERVENTIONALInicio: 21 de feb de 2024ID: NCT06012435

ReclutandoClinicalTrials.gov

Study of the Role of Genetic Modifiers in Hemoglobinopathies

OBSERVATIONALInicio: 1 de oct de 2022ID: NCT05799118

CompletadoFase 3ClinicalTrials.gov

An Open-Label Extension Of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy

INTERVENTIONALInicio: 1 de jul de 2008ID: NCT00791492